| Market Capitalization (Millions $) |
413 |
| Shares
Outstanding (Millions) |
60 |
| Employees |
485 |
| Revenues (TTM) (Millions $) |
141 |
| Net Income (TTM) (Millions $) |
-304 |
| Cash Flow (TTM) (Millions $) |
-167 |
| Capital Exp. (TTM) (Millions $) |
2 |
Business Description
Ginkgo Bioworks Holdings Inc is a biotechnology company based in the United States. It specializes in synthetic biology and genetic engineering to design and manufacture organisms for various applications. The company's primary focus is on the fields of pharmaceuticals, agriculture, and industrial chemicals. Ginkgo Bioworks utilizes its unique platform to develop custom microbes that can produce high-value molecules and materials efficiently. They have collaborated with numerous companies to enhance their production processes and create new products. Ginkgo Bioworks has gained significant attention and investment in recent years for its innovative approach to bioengineering and its potential to revolutionize various industries.
Company Address: 27 Drydock Avenue Boston 2210 MA
Company Phone Number: 422-5362 Stock Exchange / Ticker: NYSE DNA
|
0.3% 
2.57 %